Increases in serum IL-2 may be a pathway which attempts to compensate for the loss of protein kinase phosphorylation and TRPM3-dependent cell dysfunction in ME/CFS patients. Here, IL2 is linked to myalgic encephalomeyelitis/chronic fatigue syndrome.